Trial Profile
A phase IIb trial of FLX 787 in patients with nocturnal leg cramps
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Jun 2018
Price :
$35
*
At a glance
- Drugs FLX 787 (Primary)
- Indications Cramp
- Focus Therapeutic Use
- 02 Jun 2016 This trial is expected to initiate in 2017, as per the pipeline presented on the Flex Pharma Inc. website.
- 02 Jun 2016 New trial record